ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,687.60
-0.32%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) Noticias

NUWE Newellis Inc

0.1705
-0.0355 (-17.23%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Newellis Inc NUWE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0355 -17.23% 0.1705 23:00:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.215 0.1674 0.232 0.18 0.206
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202408:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
30/4/202417:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
30/4/202415:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26/4/202408:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/4/202408:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
11/3/202416:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202408:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
06/3/202411:02EDGAR2Form 8-K - Current report
05/3/202407:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05/3/202405:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
27/2/202408:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22/2/202406:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
20/2/202416:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
20/2/202407:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
08/2/202416:19EDGAR2Form S-1/A - General form for registration of securities..
06/2/202408:07EDGAR2Form 8-K - Current report
06/2/202408:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
09/1/202416:30EDGAR2Form 8-K/A - Current report: [Amend]
08/1/202408:24EDGAR2Form 8-K - Current report
04/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
13/12/202315:05EDGAR2Form 8-K - Current report
28/11/202307:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
14/11/202315:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
07/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202307:15EDGAR2Form 8-K - Current report
07/11/202307:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
01/11/202315:15EDGAR2Form 8-K - Current report
01/11/202307:00GLOBENuwellis Announces Board of Directors Transition
31/10/202307:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
18/10/202315:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
17/10/202315:30EDGAR2Form 8-K - Current report
17/10/202315:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13/10/202307:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202307:30EDGAR2Form 8-K - Current report
10/10/202307:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
06/10/202315:50EDGAR2Form POS462C - Post-effective amendment to registration..
05/10/202308:27EDGAR2Form AW - Amendment Withdrawal Request
04/10/202316:29EDGAR2Form POS AM - Post-Effective amendments for registration..
01/10/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
29/9/202307:56EDGAR2Form S-1/A - General form for registration of securities..
11/9/202315:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
06/9/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202315:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/8/202315:56EDGAR2Form 8-K - Current report
08/8/202311:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202307:25EDGAR2Form 8-K - Current report
08/8/202307:15EDGAR2Form 8-K - Current report
08/8/202307:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08/8/202307:00GLOBENuwellis Announces Plan for CFO Transition

Su Consulta Reciente

NASDAQ
NUWE
Newellis
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados